2005 Annual Symposium: Careers in Biotechnology
Guest Speakers:
Dr. Mickey Urdea, C.E.O. Tethys Bioscience, Inc.
Dr. V. Bryan Lawlis, Aradigm Corporation
Dr. Bob Bridenbaugh, Bridenbaugh Consulting
Dr. Stuart Gallant, BioMarin Pharmaceuticals
2004: NIH Biotechnology Student Poster Session
NIH Protein Biotechnology Training Program: Student Poster Session
Fall 2003 Annual Symposium: Bioterrorism: Threats and Prevention
Guest Speakers:
Dr. Stephen A. Morse and Dr. John V. Barson, Bioterrorism Preparedness and Response Program, Centers for Disease Control and Prevention
Spring 2003 Annual Symposium: Advances in Cloning Biotechnology
Guest Speakers:
Dr. Jim Hartley, Science Applications International Corporation,“Adventures in Cloning and Protein Expression”
Dr. Oliver A. Ryder, Center for Reproduction of Endangered Species,“Cloning Endangered Species”
Dr. Harry Meade, GTC Biotherapeutics, “Producting Pharmaceuticals in the Milk of Transgenic Animals”
Dr. Maurice Maloney, University of Calgary,“Production of Proteins in Plants”
Dr. Ann Gibbons, University of Guelph,“Avian Transgenesis – Approaches to Gene Targeting”
2002 – 1st Annual Fall Keynote Address: Sorting Out the Risks and Benefits of Plant Biotechnology
Guest Speaker:
Dr. R. James Cook, Washington State University
2002 Annual Symposium: Careers in Biotechnology
Guest Speakers:
Paul Bishop, Zymogenetics,“Research& Development Careers and Pharmaceutical Biotechnology”
Mark Collard, University of London,“Forensic Anthropology”
Saralynn Mandel, Adriano and Mandel,“Practicing Patent Law in the 21st Century and Remaining Sane”
Kevin Ahern, OSU,“Dancing Down the Digital Divide: The Challenge for Scientific Communicators”
Robert Gaensslen, University of Illinois,“Biotechnology in the Forensic Science Laboratory – Applications, Hype, Reality, and Potential Career Tracks”
Dana Scott, DVM OTSG,“Principles of Biological Warfare”
2001 Annual Symposium: Technology in Protein Engineering, April 14th
Guest Speakers:
Joel Cherry, Novozymes Biotech, “Industrial Enzymes: The Biotech Path to Green Chemistry”
Nathanial David, Syrrx, Inc., “Leveraging High Through-Put Structure Determination in Drug Discovery”
Jeremy Minshull, Maxygen Incorporated, “Protein Directed Evolution”
Henry Lowman, Genentech, “Structure-guided Optimization of Therapeutic Antibodies”
Christopher Murray, Genencor, “High Throughput Screening”